News Shortcuts from other journals

Chemotherapy prolongs survival after surgery for gastric cancer

BMJ 2007; 335 doi: (Published 08 November 2007) Cite this as: BMJ 2007;335:962

S-1 is an oral chemotherapy agent that combines a prodrug of fluorouracil with two enzyme inhibitors—one to stop the active drug being degraded and the other to help protect against gastrointestinal toxicity. Japanese oncologists use it to treat advanced gastric cancer, and …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to to receive unlimited access to all content on for 14 days.
Sign up for a free trial